ENSG00000167323,STIM1,calcium signaling pathway,ca2+ influx regulation,oncogenic proliferation,immune evasion mechanisms,tumor progression facilitation,therapeutic target modulation
ENSG00000144935,TRPC1,calcium signaling pathway,channel activation,cell proliferation,tumor invasion,metastasis,protein-protein interaction
ENSG00000089250,NOS1,nitric oxide production,tumor growth promotion,oncogenic signaling,immune modulation,tumor microenvironment modification,angiogenesis facilitation
ENSG00000058668,ATP2B4,calcium homeostasis disruption,oncogene activation,cell growth promotion,apoptosis inhibition,gene expression modulation,uncontrolled proliferation
ENSG00000069431,ABCC9,ion and metabolite transport,promotes cell survival,constitutive expression,cancer progression,apoptosis regulation,cellular homeostasis
ENSG00000187486,KCNJ11,increased risk mutations,cellular proliferation modulation,aberrant signaling activation,ion channel dysregulation,oncogenic process involvement,therapeutic target potential
ENSG00000084754,HADHA,fatty acid oxidation,mitochondrial function,cellular respiration,antioxidant defense,energy metabolism,lipid homeostasis
ENSG00000138029,HADHB,aerobic glycolysis,metabolic reprogramming,enhanced cell proliferation,tumor growth suppression,potential therapeutic target,energy production regulation
ENSG00000197265,GTF2E2,transcription regulation,aberrant expression,cell proliferation,oncogenic function,therapeutic target,genetic instability
ENSG00000153767,GTF2E1,transcriptional regulation,cell proliferation,oncogenic function,chromatin remodeling,apoptosis inhibition,genome stability
ENSG00000140307,GTF2A2,transcriptional regulation,cellular proliferation,genomic instability,dna repair mechanisms,antiproliferative pathways,apoptosis regulation
ENSG00000165417,GTF2A1,genomic instability,chromosomal rearrangements,dna repair mechanism,transcription initiation regulation,aneuploidy induction,tumor progression
ENSG00000162738,VANGL2,promotes cell migration,epithelial-to-mesenchymal transition,tumor progression,poor prognosis marker,cell polarity regulation,cancer metastasis
ENSG00000274287,SCRIB,planar cell polarity,tumor suppressor,epithelial polarity regulation,cell adhesion disruption,oncogenic signaling activation,metastasis promotion
ENSG00000004975,DVL2,wnt/β-catenin signaling,oncogenic driver,cell proliferation enhancement,apoptosis suppression,poor prognosis indicator,tumor progression facilitator
ENSG00000102981,PARD6A,**

cell polarity disruption,epithelial-to-mesenchymal transition,oncogenic signaling,cell cycle progression,protein-protein interactions,tumor invasion

**
ENSG00000177885,GRB2,ras/mapk signaling,oncogenic activation,cell proliferation enhancement,migration promotion,signal transduction regulation,protein-protein interaction modulation
ENSG00000109458,GAB1,oncogenic signaling,tumor progression,pi3k/akt pathway activation,cell survival promotion,epithelial morphogenesis regulation,prognostic marker
ENSG00000146648,EGFR,overexpression,constitutive activation,tumor growth,cell cycle progression,anti-apoptotic mechanisms,epithelial-to-mesenchymal transition (emt)
ENSG00000138798,EGF,egf/egfr signaling,cell proliferation,oncogenic potential,tumor progression,angiogenesis,therapeutic target
ENSG00000121879,PIK3CA,genomic instability,constitutive activation,oncogenic mutations,tumor progression,therapeutic target,signaling pathway dysregulation
ENSG00000145675,PIK3R1,pi3k/akt pathway,loss of function mutations,constitutive activation,tumor progression,therapeutic target,cellular signaling pathway
ENSG00000197122,SRC,oncogenic signaling,gain of function mutations,tumor progression,therapeutic target,cellular proliferation,signal transduction
ENSG00000089159,PXN,cell adhesion disruption,enhanced cell proliferation,metastasis promotion,oncogenic signaling,phosphorylation regulation,protein-protein interaction
ENSG00000137392,CLPS,oncogene activity,pi3k/akt pathway modulation,cell proliferation promotion,tumor progression facilitation,poor prognosis association,therapeutic target potential
ENSG00000175535,PNLIP,lipid metabolism alteration,overexpression in tumors,apoptosis resistance promotion,angiogenesis facilitation,cell proliferation enhancement,tumor invasion increase
ENSG00000078369,GNB1,gpcr regulation,heterotrimeric g-protein complex,cellular signaling pathway,constitutive activation,oncogenic transformation,pi3k/akt/mtor pathway modulation
ENSG00000127928,GNGT1,rhoa/rac1 pathway,regulatory subunit,protein-protein interaction,gpcr signaling,cancer progression,tumor growth
ENSG00000198515,CNGA1,calcium influx regulation,constitutive activation,downstream signaling pathway activation,mutation and amplification,cell proliferation enhancement,tumor progression facilitation
ENSG00000070729,CNGB1,modulation of cellular behavior,cellular growth regulation,apoptosis evasion,interactions with oncogenes,tumor progression modulation,oncogenesis contribution
ENSG00000257365,FNTB,fatty acid metabolism,lipid biosynthesis,tumorigenesis promoter,lipid accumulation,proliferation enhancer,dysregulation of expression
ENSG00000168522,FNTA,fatty acid synthesis,tumor promoter,genomic instability,lipid biosynthesis regulation,tumor microenvironment modulation,oncogenic reprogramming
ENSG00000113522,RAD50,genomic instability,dna repair disruption,loss-of-function mutations,oncogenic mutations,chromosomal instability,tumorigenesis
ENSG00000020922,MRE11,genomic instability,dna repair pathway,double-strand break repair,nhej and hr regulation,mrn complex formation,tumor progression risk
ENSG00000182481,KPNA2,nuclear transport regulation,cell proliferation enhancement,tumor growth promotion,metastasis facilitation,protein import regulation,angiogenesis modulation
ENSG00000104320,NBN,genomic instability,dna repair mechanisms,homologous recombination repair (hrr),oncogenic consequences,cancer development prevention,mrn complex interaction
ENSG00000172977,KAT5,histone acetylation,chromatin regulation,oncogene activation,genomic instability,apoptosis inhibition,cell cycle progression
ENSG00000149311,ATM,genomic instability,dna damage response,cell cycle regulation,apoptosis induction,checkpoint kinase activation,tumor suppression
ENSG00000009954,BAZ1B,chromatin remodeling,oncogenic transformation,aggressive tumor behavior,cancer progression,therapeutic target,transcriptional regulation
ENSG00000153147,SMARCA5,chromatin remodeling,tumor suppressor function,loss of function mutations,epigenetic alterations,gene expression dysregulation,dna damage response
ENSG00000103275,UBE2I,ubiquitin-conjugating enzyme activity,cell cycle regulation,tumor progression,oncogene activation,protein degradation,therapeutic target
ENSG00000116030,SUMO1,protein modification,regulation of protein activity,cell cycle progression,tumor suppressor degradation,oncogenic protein stabilization,dna repair dysregulation
ENSG00000169139,UBE2V2,protein degradation,tumor suppressor regulation,cell proliferation,survival pathway,ubiquitination complex,genomic instability
ENSG00000177889,UBE2N,protein degradation regulation,tumor suppressor degradation,ubiquitination pathway modulation,onco-protein stabilization,transcription factor regulation,cancer progression
ENSG00000138376,BARD1,genetic instability,dna damage response,homologous recombination,cell cycle regulation,tumor suppressor function,apoptosis induction
ENSG00000012048,BRCA1,genomic instability,dna damage response,homologous recombination repair,apoptosis regulation,transcriptional regulation,cell cycle progression
ENSG00000188612,SUMO2,cellular proliferation,mitotic progression,centrosome function,oncogenic pathway modulation,post-translational modification regulation,tumor growth promotion
ENSG00000225589,MDC1,double-strand break repair,genomic instability,histone modification,oncogenic signaling,protein-protein interaction,tumor suppressor dysfunction
ENSG00000128731,HERC2,protein degradation,ubiquitination activity,tumor suppressor protein degradation,oncoprotein regulation,cell cycle progression,cancer prognosis marker
ENSG00000164053,ATRIP,dna damage response,cell cycle progression,genomic instability,tumor suppressor activity,checkpoints activation,chk1 regulation
ENSG00000175054,ATR,genomic instability,dna damage response,cell cycle regulation,tumor progression,checkpoint activation,apoptosis inhibition
ENSG00000111602,TIMELESS,chromatin remodeling,genome stability maintenance,cell cycle progression regulation,atrip interaction,oncogenic driver,apoptosis evasion
ENSG00000075131,TIPIN,genomic integrity,cell cycle regulation,dna replication,genomic stability,chromosomal instability,oncogene regulation
ENSG00000163605,PPP4R2,pp4 regulation,tumor progression,cancer cell survival,cell cycle regulation,protein phosphatase modulation,apoptosis resistance
ENSG00000149923,PPP4C,dna replication,genomic instability,cell cycle regulation,tumor progression,protein phosphatase activity,poor prognostic marker
ENSG00000108384,RAD51C,genomic instability,dna repair mechanism,homologous recombination,tumor progression,genetic predisposition,oncogenesis
ENSG00000126215,XRCC3,homologous recombination,genomic instability,genome integrity,dna repair pathway,tumor progression,therapeutic target
ENSG00000197774,EME2,genomic instability,chromatin remodeling,swi/snf complex,transcriptional regulation,dna repair mechanism,cell proliferation
ENSG00000172732,MUS81,dna repair,genomic instability,homologous recombination,single-strand annealing,chromatin remodeling,tumor progression
ENSG00000154920,EME1,genome instability,tumor suppressor activity,cell cycle regulation,dna replication,chromatin remodeling,oncogenesis
ENSG00000139618,BRCA2,genomic instability,dna repair mechanisms,tumor suppressor functions,homologous recombination,genetic mutations,cancer risk modifier
ENSG00000051180,RAD51,homologous recombination repair,genome instability,oncogenic mutations,interstrand crosslinks,dna repair mechanisms,chromosomal integrity
ENSG00000175595,ERCC4,genomic instability,dna damage response,nucleotide excision repair,cell cycle checkpoint activation,epigenetic alterations,apoptosis
ENSG00000012061,ERCC1,dna repair mechanism,nucleotide excision repair,resistance to chemotherapy,genomic instability,tumor progression,sensitivity to platinum-based chemotherapies
ENSG00000073050,XRCC1,dna repair,genomic instability,scaffold protein function,base excision repair pathway,biomarker for therapy response,cellular resistance to chemotherapy
ENSG00000005156,LIG3,dna damage response,genomic instability,single-strand breaks,dna repair mechanisms,mutagenesis,tumor development
ENSG00000196419,XRCC6,genomic instability,dna damage repair,tumor progression,cellular response modulation,protein interaction disruption,oncogenesis
ENSG00000079246,XRCC5,**

genomic stability,dna double-strand break repair,non-homologous end joining,ku70-parp1 interaction,genetic instability,epigenetic regulation 
**
ENSG00000152422,XRCC4,dna repair mechanism,nhej pathway,genomic instability,tumor progression,platinum-based chemoresistance,cancer resistance
ENSG00000174405,LIG4,ligase activity,genomic instability,gene fusion,dna repair deficiency,oncogene activation,genetic mutation
ENSG00000049860,HEXB,glucocerebrosidase activity,cell growth regulation,lysosomal function disruption,apoptosis evasion,autophagy modulation,metabolic reprogramming
ENSG00000213614,HEXA,altered metabolism,glycosphingolipid catabolism,lysosomal degradation,cellular growth regulation,metabolic adaptation,enzyme dysfunction
ENSG00000151348,EXT2,o-glycan processing,tumor progression,enhanced cell adhesion,glycosylation pathway dysregulation,cartilage tumor formation,cell migration and invasion
ENSG00000182197,EXT1,heparan sulfate biosynthesis,angiogenesis promotion,cellular interaction regulation,tumor progression facilitation,extracellular matrix modification,glycosyltransferase function
ENSG00000115904,SOS1,gef activity,ras activation,oncogenic mutations,mapk/erk pathway,cell proliferation,genomic instability
ENSG00000170312,CDK1,cell cycle regulation,mitotic catastrophe,tumor progression,genomic instability,centrosome amplification,therapeutic target
ENSG00000134057,CCNB1,cell cycle regulation,g2/m transition,cell proliferation,oncogenesis,poor prognosis,therapeutic target
ENSG00000165494,PCF11,dna damage suppression,genomic stability maintenance,chromatin remodeling regulation,transcriptional control modulation,oncogenesis promotion,therapeutic target
ENSG00000172409,CLP1,genomic instability,dna helicase activity,tumor suppressor function,oncogenic process contribution,prognostic marker potential,therapeutic target candidate
ENSG00000187079,TEAD1,transcription factor regulation,cell cycle progression,tumor progression,epithelial-to-mesenchymal transition,oncogenic complex formation,prognostic marker
ENSG00000137693,YAP1,tead transcriptional regulation,hippo signaling pathway,cell growth promotion,constitutive activation,epithelial-to-mesenchymal transition,transcriptional coactivation
ENSG00000074219,TEAD2,transcription factor regulation,cell cycle progression,dna repair evasion,oncogenic signaling pathway,epithelial-to-mesenchymal transition,hippo-yap axis activation
ENSG00000007866,TEAD3,tea domain transcription factor,wnt/β-catenin signaling pathway activation,cell growth regulation,cancer stem cell maintenance,epithelial-to-mesenchymal transition (emt),transcriptional repressor of p21 expression
ENSG00000197905,TEAD4,tead4- hippo pathway interaction,cell proliferation enhancement,epithelial-to-mesenchymal transition (emt),transcriptional activation,altered chromatin structure,gene expression regulation
ENSG00000132964,CDK8,transcriptional regulation,oncogene activation,cell cycle progression,proliferation promotion,metastasis enhancement,therapeutic target
ENSG00000112237,CCNC,centrosome component 1 overexpression,chromosomal instability,cell cycle regulation,protein-protein interactions,aneuploidy,cell proliferation enhancement
ENSG00000101665,SMAD7,tumor suppressor function,cell proliferation inhibition,apoptosis induction,negative regulator of tgf-β pathway,transforming growth factor-beta signaling,cancer cell regulation
ENSG00000157450,RNF111,p53 regulation,ubiquitin ligase activity,cell cycle progression,tumor suppressor inhibition,epithelial-to-mesenchymal transition (emt),oncogene overexpression
ENSG00000284792,PTEN,loss of tumor suppressor function,pi3k/akt signaling pathway regulation,cell survival enhancement,genomic instability promotion,metabolic regulation disruption,akt phosphorylation inhibition
ENSG00000141510,TP53,genomic instability,apoptosis evasion,tumor suppressor function,cell cycle regulation,pro-apoptotic target activation,transcriptional regulation
ENSG00000165699,TSC1,mtor pathway,constitutive activation,loss of function mutations,tumor suppressor,cell growth regulation,metabolic regulation
ENSG00000103197,TSC2,mtor pathway activation,loss-of-function mutations,pi3k/akt signaling regulation,cell proliferation promotion,tumor suppressor function loss,genomic instability contribution
ENSG00000284194,SCO2,mitochondrial dysfunction,electron transport chain disruption,genomic instability,ros production,tumor progression,rna regulation
ENSG00000048392,RRM2B,dna replication regulation,genomic instability promotion,mitochondrial function impairment,oncogene overexpression,ribonucleotide reductase activation,tumor aggressiveness marker
ENSG00000135423,GLS2,glutamine metabolism,cellular proliferation,metabolic reprogramming,tumor growth,energy production,protein interaction
ENSG00000146674,IGFBP3,cell cycle regulation,apoptosis induction,angiogenesis inhibition,tumor suppressor,igf-i binding,vegf interaction
ENSG00000141682,PMAIP1,apoptosis regulation,tumor suppressor function,mitochondrial outer membrane permeabilization,genomic instability,chromosomal abnormalities,protein-protein interaction
ENSG00000015475,BID,apoptosis suppression,pro-apoptotic function,cell survival enhancement,tumor progression promotion,apoptotic pathway modulation,b-cell receptor signaling
ENSG00000120471,TP53AIP1,tp53 regulation,cell cycle regulation,apoptosis modulation,dna repair interaction,tumor suppressor activity,mutations in cancer
ENSG00000197050,ZNF420,tumor suppressor,epigenetic regulation,cellular proliferation,apoptosis induction,genome stability maintenance,krab domain-containing zinc finger protein family
ENSG00000115107,STEAP3,iron regulation,metalloreductase activity,genetic instability,oncogene upregulation,protein-protein interaction,reactive oxygen species production
ENSG00000104765,BNIP3L,apoptosis inhibition,oncogenic process promotion,mitochondrial function regulation,cellular proliferation enhancement,anti-apoptotic activity induction,tumorigenesis facilitation
ENSG00000170855,TRIAP1,genomic instability,tumor suppressor,cell cycle regulation,p53 pathway modulation,dna repair disruption,loss-of-function mutations
ENSG00000042286,AIFM2,mitochondrial homeostasis,reactive oxygen species regulation,cell proliferation enhancement,oncogenic signaling activation,tumor progression promotion,therapeutic target candidacy
ENSG00000164938,TP53INP1,mitotic regulation,genomic stability,apoptosis induction,cell cycle inhibition,tumor suppression,dna repair pathway interaction
ENSG00000120868,APAF1,apoptosis regulation,tumor suppressor function,genomic instability,mitochondrial pathway activation,cancer progression inhibition,protein-protein interaction modulation
ENSG00000177595,PIDD1,apoptosis regulation,tumor suppressor function,dna damage response,genomic instability,caspase activation,rip1 interaction
ENSG00000169372,CRADD,tumor suppression,apoptosis regulation,pro-apoptotic protein interaction,cell migration inhibition,pi3k/akt signaling modulation,genomic downregulation
ENSG00000091106,NLRC4,nf-κb activation,innate immune response,inflammatory cytokines,tumor microenvironment,immune modulation,cell signaling
ENSG00000138794,CASP6,tumor suppressor,apoptosis regulation,cell death induction,cancer progression,mitotic checkpoint,dna damage response
ENSG00000003400,CASP10,apoptosis regulation,tumor progression,therapeutic target,protein interaction,cancer resistance,cell survival
ENSG00000104419,NDRG1,epigenetic regulation,gene silencing,tumor suppression,cellular differentiation,apoptosis modulation,transcriptional regulation
ENSG00000281449,BCL2L14,anti-apoptotic function,tumor progression,therapeutic target,cell survival promotion,prognostic marker,oncogenic protein interaction
ENSG00000089685,BIRC5,apoptosis inhibition,cell cycle regulation,cancer progression,poor prognosis,genomic instability,transcriptional regulation
ENSG00000113916,BCL6,transcriptional repression,cell cycle regulation,apoptosis inhibition,tumor cell proliferation,cancer driver,protein-protein interaction
ENSG00000161642,ZNF385A,tumor suppressor function,cell cycle regulation,apoptosis induction,pi3k/akt pathway inhibition,transcription factor activity,dna repair regulation
ENSG00000116017,ARID3A,chromatin remodeling,genomic instability,telomere maintenance,atrx-related transcription factor 1,double-strand break repair,coactivator protein
ENSG00000165891,E2F7,regulation of cell cycle,transcriptional regulation,overexpression in cancer,dna-binding domain,cell proliferation promotion,microrna regulation
ENSG00000129173,E2F8,cell cycle regulation,transcription factor activity,overexpression,cell proliferation,chromatin modification,proliferative signaling
ENSG00000116717,GADD45A,apoptosis regulation,cell cycle progression,dna damage response,genomic instability,oncogene cooperation,protein-protein interaction
ENSG00000087586,AURKA,aurora kinase activation,cell division regulation,centrosome amplification,genomic instability,oncogenic processes enhancement,therapeutic target
ENSG00000132646,PCNA,dna replication,cellular proliferation,oncogenic pathways,cell cycle regulation,genomic instability,therapeutic target
ENSG00000087088,BAX,apoptosis regulation,tumor suppressor function,mitochondrial permeabilization,bcl-2 family interactions,methylation-mediated silencing,therapeutic target
ENSG00000175793,SFN,apoptosis inhibition,cell proliferation enhancement,tumor progression association,prognostic marker,oncogene function,cell cycle regulation modulation
ENSG00000145632,PLK2,apoptosis resistance,cell cycle regulation,chromosomal instability,oncogenic driver,pi3k/akt pathway activation,protein phosphorylation
ENSG00000173846,PLK3,**

cell cycle regulation,oncogenic properties,constitutive activation,cell proliferation enhancement,apoptosis inhibition,dna damage response modulation
ENSG00000102760,RGCC,chromatin remodeling,oncogenic mutations,cell cycle progression,dna repair regulation,genomic instability,therapeutic target
ENSG00000118495,PLAGL1,transcriptional regulation,overexpression,tumor suppressor silencing,cell proliferation promotion,oncogenic pathway activation,apoptosis resistance
ENSG00000115966,ATF2,constitutive activation,genomic instability,transcriptional regulation,cell proliferation,angiogenesis induction,p53 interaction
ENSG00000177606,JUN,transcriptional regulation,oncogenesis,cell proliferation,transcription factor activation,ap-1 complex,mapk signaling pathway
ENSG00000170345,FOS,ap-1 transcription factor,tumor progression,cell proliferation,oncogenic activation,signaling pathway modulation,genomic instability
ENSG00000122512,PMS2,genomic instability,dna mismatch repair pathway,loss of function mutations,microsatellite instability,tumor suppressor function,chromosomal instability
ENSG00000076242,MLH1,microsatellite instability,mismatch repair deficiency,dna replication errors,genetic instability,tumor progression,immunotherapy target
ENSG00000158169,FANCC,dna repair,genetic instability,tumor suppression,interstrand crosslink repair,cell cycle regulation,cancer driver gene
ENSG00000134574,DDB2,genetic instability,nucleotide excision repair,dna damage recognition,tumor suppressor function,mutational burden,dna repair deficiency
ENSG00000057657,PRDM1,immune evasion,epigenetic regulation,histone modification,oncogene expression,tumor suppressor function,cell survival promotion
ENSG00000135679,MDM2,p53 regulation,oncogenic process activation,tumor suppression inhibition,apoptosis prevention,genetic instability promotion,cell cycle dysregulation
ENSG00000198625,MDM4,p53 inhibition,tumor suppression inhibition,genetic amplification,cell cycle regulation modulation,anti-apoptotic activity,prognostic biomarker potential
ENSG00000113328,CCNG1,apoptosis regulation,cell cycle disruption,cdk2 interaction,p53 pathway suppression,cancer progression driver,tumor suppressor downregulation
ENSG00000064393,HIPK2,apoptosis regulation,p53 pathway activation,serine/threonine kinase activity,genomic instability contribution,tumor suppressor function,cell cycle regulation interaction
ENSG00000127445,PIN1,cell cycle progression,tumor development,protein degradation,apoptosis regulation,metastasis promotion,therapeutic target
ENSG00000163349,HIPK1,apoptosis regulation,tumor suppressor function,p53 activation,cell cycle arrest,genomic stability,protein kinase activity
ENSG00000149136,SSRP1,chromatin remodeling,dna replication and repair,cell cycle progression,transcriptional regulation,poor prognosis marker,genome stability maintenance
ENSG00000092201,SUPT16H,genomic instability,chromatin remodeling complex,dna repair dysfunction,tumor suppressor gene regulation,oncogene activation,apoptosis dysregulation
ENSG00000101266,CSNK2A1,ck2/cdk4 pathway disruption,protein kinase activation,cell cycle dysregulation,tumor progression,therapeutic target potential,genomic instability
ENSG00000070770,CSNK2A2,dysregulated signaling,overexpression driven,cell cycle regulation,protein kinase activity,tumor progression,chemotherapy resistance
ENSG00000088325,TPX2,mitotic spindle formation,overexpression in tumors,genomic instability,increased proliferation rates,oncogene role,microtubule dynamics regulation
ENSG00000188976,NOC2L,**
genomic instability,cell division regulation,spindle formation modulation,mitotic progression control,cancer driver mutation,somatic mutation hotspot **
ENSG00000176749,CDK5R1,cancer progression,gain of function mutations,tumor growth and survival,genomic instability,oncogenic pathway activation,cell cycle regulation
ENSG00000164885,CDK5,cell cycle regulation,protein phosphorylation,tumor progression,oncogenic activation,genomic instability,therapeutic target
ENSG00000152192,POU4F1,transcription factor regulation,enhanced cell proliferation,tumor progression,therapeutic target,cell cycle regulation,dna repair resistance
ENSG00000151615,POU4F2,transcription factor regulation,cell proliferation,oncogene activity,tumor suppressor inhibition,genomic instability,epigenetic modulation
ENSG00000172530,BANP,chromatin regulation,transcriptional regulator,cell proliferation,gene expression modulation,tumor progression,metastasis
ENSG00000025293,PHF20,chromatin remodeling,transcriptional regulation,epigenetic regulator,oncogene overexpression,tumor suppressor dysfunction,genome instability
ENSG00000185513,L3MBTL1,chromatin regulation,tumor suppressor function,loss of heterochromatin protein 1 binding,apoptosis promotion,cycle progression inhibition,dna damage response regulation
ENSG00000238134,EHMT2,epigenetic regulation,chromatin compaction,gene silencing,genomic instability,tumor suppressor gene regulation,oncogenic interaction
ENSG00000181090,EHMT1,epigenetic regulation,tumor suppressor function,methyltransferase activity,cell proliferation regulation,differentiation pathway modulation,histone methylation
ENSG00000137203,TFAP2A,oncogene regulation,transcriptional modulation,cell proliferation enhancement,genetic amplification,angiogenesis promotion,epigenetic modification
ENSG00000124795,DEK,oncogene,nucleolar phosphoprotein,cell proliferation regulator,transcriptional coactivator,histone modification regulator,subcellular localization-dependent function
ENSG00000087510,TFAP2C,oncogene regulation,cell cycle progression,transcriptional regulation,ectopic expression,apoptosis resistance,epithelial-to-mesenchymal transition
ENSG00000186153,WWOX,ww domain interaction,apoptosis regulation,cell proliferation inhibition,tumor suppressor function,promoter methylation resistance,tumor cell apoptosis induction
ENSG00000008196,TFAP2B,tumor progression,oncogenic function,transcriptional regulation,cell proliferation,apoptosis evasion,epigenetic modification
ENSG00000127337,YEATS4,altered gene expression,chromatin regulation disruption,genome instability,histone recognition dysfunction,homologous recombination repair impairment,oncogenic processes facilitation
ENSG00000091831,ESR1,erα activation,hormone-dependent proliferation,increased angiogenesis,oncogenic signaling,tumor growth regulation,therapeutic target
ENSG00000156802,ATAD2,chromatin remodeling,cell cycle progression,dna replication,homologous recombination repair,tumor suppressor regulation,oncogenic transcriptional regulation
ENSG00000112715,VEGFA,angiogenic signaling,tumor progression,constitutive activation,cell migration,survival pathways,vascular permeability
ENSG00000163235,TGFA,egf/egfr signaling pathway,overexpression,cell proliferation,tumor progression,therapeutic target,oncogenic protein
ENSG00000124762,CDKN1A,cell cycle regulation,tumor suppressor function,dual role in tumorigenesis,apoptosis induction,dna damage response,cell proliferation inhibition
ENSG00000159216,RUNX1,oncogene activation,cell proliferation regulation,transcriptional regulation,hematopoiesis dysregulation,apoptosis inhibition,tumor suppressor downregulation
ENSG00000078900,TP73,tumor suppressor function,genomic instability prevention,apoptosis modulation,dna repair regulation,cancer driver mutation,tumor progression modulation
ENSG00000179588,ZFPM1,epithelial-to-mesenchymal transition,transcription factor overexpression,gene regulation,cancer progression,biomarker potential,cell proliferation modulation
ENSG00000102145,GATA1,gata motif binding,tumor suppressor function,oncogenic activation,cell proliferation regulation,epithelial-to-mesenchymal transition,transcription factor activity
ENSG00000143387,CTSK,metastatic progression,extracellular matrix degradation,oncogenic signaling,proteolytic activity,cancer cell invasion,tumor aggressiveness
ENSG00000197641,SERPINB13,cellular regulation,anti-tumor activity,metastasis suppression,proliferation pathway,tumor suppression,malignant transformation
ENSG00000110092,CCND1,g1 phase progression,cyclin-dependent kinase activation,retinoblastoma protein phosphorylation,cell cycle dysregulation,genomic instability,oncogenic driver
ENSG00000135446,CDK4,cell cycle regulation,oncogenic driver,cell proliferation enhancement,tumor suppression evasion,protein interaction modulation,genetic amplification hotspot
ENSG00000173153,ESRRA,estrogen-related receptor regulation,constitutive activation,oncogene function,cell proliferation promotion,tumor progression,genomic instability
ENSG00000109819,PPARGC1A,**
metabolic reprogramming,glycolysis enhancement,lipid biosynthesis promotion,transcriptional regulation,oncogenic function,therapeutic target 
**
